Techne Corp. 614 McKinley Place NE Minneapolis,
MN 55413-2610 United States - Map Phone: 612-379-8854 Fax: 612-379-6580 Website: http://www.techne-corp.com
TECHNE Corporation develops, manufactures, and sells biotechnology products, and hematology calibrators and controls worldwide. The companys Biotechnology segment offers proteins, such as cytokines, and enzyme substrates and inhibitors; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits for the detection of human and animal proteins, and immunoassays that allow researchers to quantify a specific analyte in a biological fluids sample; clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and beta2-microglobulin immunoassays for use as in vitro diagnostic devices; flow cytometry products, such as fluorochrome labeled antibodies and kits; intracellular cell signaling products, including antibodies, phospho-specific antibodies, antibody arrays, active caspases, kinases, and phosphatases, and ELISA assays to measure the activity of apoptotic and signaling molecules; and natural and synthetic chemical compounds for use as agonists, antagonists, and inhibitors of various biological functions by investigators. Its Hematology segment provides whole blood CBC controls controls and calibrators; linearity and reportable range controls for the assessment of the linearity of hematology analyzers for white blood cells, red blood cells, platelets, and reticulocytes; whole blood reticulocyte controls for manual and automated counting of reticulocytes; whole blood flow cytometry controls for the identification and quantification white blood cells; whole blood glucose/hemoglobin control to monitor instruments, which measure glucose and hemoglobin in blood; erythrocyte sedimentation rate control to monitor erythrocyte sedimentation rate tests; and multi-purpose platelet reference controls, such as Platelet-Trol II and Platelet-Trol Extended for use by automated and semi-automated analyzers, which monitor platelet levels. The company was founded in 1976 and is headquartered in Minneapolis, Minnesota. Key Statistics
| |
| Techne Corp.’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Low Concern), Board (High Concern), Compensation (Low Concern), Shareholder Rights (Low Concern). | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Thomas E. Oland ,
71 Chairman, Chief Exec. officer and Pres | 266.00K | 0.00 | Dr. Roger C. Lucas Ph.D.,
69 Vice Chairman, Director, Sr. Scientific Advisor, Member of Nominations & Governance Committee and Member of Scientific Subcommittee | 28.00K | N/A | Mr. Gregory J. Melsen ,
60 Chief Financial officer, VP of Fin. and Treasurer | 326.00K | 0.00 | Mr. Marcel Veronneau ,
58 VP of Hematology Operations | 210.00K | 402.00K | Kathleen M. Backes ,
Chief Accounting Officer and Controller | N/A | N/A |
|
| | Amounts are as of Dec 30, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|